| Abstrakt: |
Genprex, Inc., a biopharmaceutical company, has filed a Form 424B5 with the U.S. Securities and Exchange Commission (SEC) on December 13, 2023. The company's SIC code is 2834, Pharmaceutical Preparations. The filing includes 4 documents and the SEC file number is 0001437749-23-034346. Genprex, Inc. is located at 1601 Trinity Street, Bldg. B, Suite 3.322, Austin, TX 78712, with a contact number of 512-537-7997. The filing is a prospectus filed pursuant to Rule 424(b)(5). For more information, the SEC filing can be found at https://www.sec.gov/Archives/edgar/data/1595248/0001437749-23-034346-index.html. [Extracted from the article] |
